Priser
Platform
Blog
Om os
Download
Hangzhou Jiuyuan Genetic Biopharmaceutical Co
Hangzhou Jiuyuan Genetic Biopharmaceutical Co
Hong Kong Stock Exchange
0

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I HANGZHOU JIUYUAN GENETIC BIOPHARMACEUTICAL CO MED ENDAVU: Køb Hangzhou Jiuyuan Genetic Biopharmaceutical Co ($2566) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Hangzhou Jiuyuan Genetic Biopharmaceutical Co, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Om

Hangzhou Jiuyuan Gene Engineering Co., Ltd. is a company specializing in genetic engineering and biotechnology applications. The primary function of this company is to research, develop, and manufacture genetic products and solutions that cater to various industries, predominantly within the healthcare and pharmaceutical sectors. Notably, the company focuses on the production of cell culture medias and reagents, essential for biological research and production processes.

Hangzhou Jiuyuan Gene Engineering plays a significant role in advancing genetic research methodologies and enhancing biotechnology innovations. Through its comprehensive product offerings, the company contributes to the proliferation of genetic solutions aimed at improving health outcomes. Its work supports pharmaceutical companies, research institutions, and academic labs, streamlining processes associated with genetic manipulation and molecular biology research.

Positioned in a rapidly evolving field, Hangzhou Jiuyuan Gene Engineering is notable for aiding in the development of new therapeutic options and diagnostic tools, reflecting the growing importance of genetics in modern medicine. The company's endeavors align with the increasing global emphasis on precision medicine and the creation of personalized treatment strategies.

Information

Ticker2566
Land
Kina
Antal medarbejdere1.794
Hjemmesidechina-gene.com
SektorSundhed
IndustriBioteknologi

Udbytter

0,06HKD
'25
0,07HKD
'26
Ex-udbytte-dato17. jun. 2026
Udbytteafkast1,06%